Profile
Sector:
HealthcareIndustry:
Medical DevicesCountry:
United StatesIPO:
29 March 2021Website:
http://www.allurion.comNext earnings report:
18 October 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Wed, 03 Jul 2024 20:42:13 GMTDividend
Analysts recommendations
Institutional Ownership
ALUR Latest News
NATICK, Mass.--(BUSINESS WIRE)--Allurion Technologies, Inc. (NYSE: ALUR) (“Allurion” or the “Company”), a company dedicated to ending obesity, today announced that it has launched an underwritten public offering of up to $20 million of its common stock, par value $0.0001 per share (the “Shares”), and warrants to purchase Shares (the “Warrants” and, together with the Shares, the “Securities”). Jefferies and TD Cowen are acting as joint book-running managers and representatives of the underwriter.
Allurion (ALUR) announces positive weight loss data for its gastric balloon technology.
The heavy selling pressure might have exhausted for Allurion Technologies, Inc. (ALUR) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
NATICK, Mass.--(BUSINESS WIRE)---- $ALUR #Allurion--Allurion Technologies, Inc. (NYSE:ALUR), a company dedicated to ending obesity, today announced the appointment of Ojas A. Buch as its new Chief Operating Officer. Effective June 3, 2024, Ojas assumed the role of Chief Operating Officer and will lead the company's Research and Development, Manufacturing and Operations, Quality and Regulatory, and Business Development and Innovation functions. He will also play a crucial role in commercial functions while working.
NATICK, Mass.--(BUSINESS WIRE)---- $ALUR #Allurion--Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced the expansion of its Artificial Intelligence (AI)-powered weight loss coach, Coach Iris, to support patients prescribed GLP-1s and other anti-obesity medications and the first commercial agreements for its Virtual Care Suite (VCS) in the United States. With this update to Coach Iris, patients now have access to 24/7 personalized coaching and guidance specific to GLP-1.
Little-known medical device firm Allurion (NYSE: ALUR ) — which is focused on ending obesity via its swallowable and “procedure-less” intragastric balloon — saw its shares skyrocket on Thursday. Earlier this morning, management announced the commercial availability of its comprehensive Virtual Care Suite (VCS) in the U.S. ALUR stock likely benefited from rising interest in anti-obesity treatments.
Allurion Technologies Inc. (ALUR) Q4 2023 Earnings Call Transcript
Allurion Technologies Inc. (NYSE:ALUR ) Q3 2023 Results Conference Call November 13, 2023 8:30 AM ET Company Participants Mike Cavanaugh - ICR of Westwicke Shantanu Gaur - Founder and Chief Executive Officer Chris Geberth - Chief Financial Officer Conference Call Participants Anthony Petrone - Mizuho Ross Osborn - Cantor Fitzgerald Ryan Zimmerman - BTIG Chris Pasquale - Nephron Research Operator Hello, and welcome to the Allurion Third Quarter Earnings Call. All lines have been placed on mute to prevent any background noise.
What type of business is Allurion Technologies?
Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon) and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. The company is headquartered in Natick, Massachusetts.
What sector is Allurion Technologies in?
Allurion Technologies is in the Healthcare sector
What industry is Allurion Technologies in?
Allurion Technologies is in the Medical Devices industry
What country is Allurion Technologies from?
Allurion Technologies is headquartered in United States
When did Allurion Technologies go public?
Allurion Technologies initial public offering (IPO) was on 29 March 2021
What is Allurion Technologies website?
https://www.allurion.com
Is Allurion Technologies in the S&P 500?
No, Allurion Technologies is not included in the S&P 500 index
Is Allurion Technologies in the NASDAQ 100?
No, Allurion Technologies is not included in the NASDAQ 100 index
Is Allurion Technologies in the Dow Jones?
No, Allurion Technologies is not included in the Dow Jones index
When does Allurion Technologies report earnings?
The next expected earnings date for Allurion Technologies is 18 October 2024